IE851295L - Monoclonal human mif - Google Patents
Monoclonal human mifInfo
- Publication number
- IE851295L IE851295L IE851295A IE129585A IE851295L IE 851295 L IE851295 L IE 851295L IE 851295 A IE851295 A IE 851295A IE 129585 A IE129585 A IE 129585A IE 851295 L IE851295 L IE 851295L
- Authority
- IE
- Ireland
- Prior art keywords
- human mif
- monoclonal antibodies
- mif
- derivatives
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
The invention relates to purified human macrophage migration inhibitory factor (human MIF) and its individual proteins, to a process for the purification of human MIF and for the isolation of its individual proteins, to monoclonal antibodies against human MIF, derivatives thereof, processes for the preparation of these antibodies and derivatives thereof, hybridoma cell lines which produce these antibodies, processes for the preparation of said hybridoma cell lines, and to the use of the monoclonal antibodies and derivatives thereof for the qualitative and quantitative determination of human MIF in biological fluids and on cell surfaces, and to the use of the monoclonal antibodies for the purification of human MIF. Human MIF and monoclonal antibodies against human MIF are important for the diagnosis and therapy of immunoregulatory disorders and chronic inflammatory disorders.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH255784 | 1984-05-24 | ||
CH378684 | 1984-08-07 | ||
CH544684 | 1984-11-14 | ||
CH51285 | 1985-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE851295L true IE851295L (en) | 1985-11-24 |
IE60450B1 IE60450B1 (en) | 1994-07-13 |
Family
ID=27427909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE129585A IE60450B1 (en) | 1984-05-24 | 1985-05-23 | Lymphokine in pure form, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0162812B1 (en) |
JP (3) | JPH0672158B2 (en) |
AT (1) | ATE93869T1 (en) |
DE (1) | DE3587553D1 (en) |
DK (1) | DK171646B1 (en) |
ES (3) | ES8702950A1 (en) |
IE (1) | IE60450B1 (en) |
IL (1) | IL75280A0 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263072B1 (en) | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
GB8623850D0 (en) * | 1986-10-03 | 1986-11-05 | Ciba Geigy Ag | Lymphokine related peptide |
EP0463037A1 (en) * | 1989-03-17 | 1992-01-02 | Genetics Institute, Inc. | Human macrophage migration inhibitory factor |
GB8915414D0 (en) * | 1989-07-05 | 1989-08-23 | Ciba Geigy | Novel cytokines |
US5107906A (en) * | 1989-10-02 | 1992-04-28 | Swenson Paul F | System for fast-filling compressed natural gas powered vehicles |
US5149544A (en) * | 1989-11-13 | 1992-09-22 | Research Corporation Technologies, Inc. | Method of inhibiting progenitor cell proliferation |
AU692159B2 (en) * | 1993-05-17 | 1998-06-04 | Cytokine Pharmasciences, Inc. | Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
US6080407A (en) * | 1993-05-17 | 2000-06-27 | The Picower Institute For Medical Research | Diagnostic assays for MIF |
WO2001064749A2 (en) * | 2000-02-28 | 2001-09-07 | Idec Pharmaceuticals Corporation | Method for preparing anti-mif antibodies |
DE10121255A1 (en) | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | Use of alpha 1-antichymotrypsin polypeptide or nucleic acids encoding the polypeptide, or of a cell expressing the polypeptide, or of antibody against the polypeptide, for diagnosing, treating or preventing poorly-healing wounds |
UY27304A1 (en) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | INHIBITORS OF THE INHIBITOR FACTOR OF MIGRATION OF MACROPHAGES AND METHODS FOR IDENTIFICATION |
TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
EP1861407A1 (en) | 2005-03-24 | 2007-12-05 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
CN100457895C (en) * | 2006-05-24 | 2009-02-04 | 中国科学院生物物理研究所 | Rat antihuman macrephage migration inhibiting factor monoclone antibody and its application |
JP2014530360A (en) * | 2011-10-07 | 2014-11-17 | バクスター・ヘルスケヤー・ソシエテ・アノニムBaxter Healthcare SA | OxMIF as a diagnostic marker |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2755363C3 (en) * | 1977-12-12 | 1983-12-01 | R & Z Biologicals Beteiligungsgesellschaft mbH, 4050 Mönchengladbach | Test method for diagnosing malignancies |
US4299814A (en) * | 1979-05-25 | 1981-11-10 | Monsanto Company | Radioimmunoassay of MIF |
JPS5939832A (en) * | 1982-08-28 | 1984-03-05 | Ajinomoto Co Inc | Monoclonal antibody and preparation and use thereof |
DD230876A1 (en) * | 1983-05-09 | 1985-12-11 | Akad Wissenschaften Ddr | PROCESS FOR OBTAINING MONOCLONAL ANTIBODY AGAINST HUMAN MIF |
-
1985
- 1985-03-11 JP JP60046694A patent/JPH0672158B2/en not_active Expired - Lifetime
- 1985-05-15 AT AT85810232T patent/ATE93869T1/en not_active IP Right Cessation
- 1985-05-15 EP EP85810232A patent/EP0162812B1/en not_active Expired - Lifetime
- 1985-05-15 DE DE85810232T patent/DE3587553D1/en not_active Expired - Fee Related
- 1985-05-22 ES ES543391A patent/ES8702950A1/en not_active Expired
- 1985-05-22 IL IL75280A patent/IL75280A0/en unknown
- 1985-05-23 IE IE129585A patent/IE60450B1/en not_active IP Right Cessation
- 1985-05-23 DK DK229985A patent/DK171646B1/en not_active IP Right Cessation
-
1986
- 1986-09-16 ES ES557071A patent/ES8801852A1/en not_active Expired
- 1986-09-16 ES ES557072A patent/ES8801850A1/en not_active Expired
-
1993
- 1993-09-30 JP JP5244287A patent/JPH0780915B2/en not_active Expired - Lifetime
-
1994
- 1994-03-14 JP JP6042201A patent/JPH07108915B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH06217789A (en) | 1994-08-09 |
ES557072A0 (en) | 1987-08-01 |
DK229985D0 (en) | 1985-05-23 |
EP0162812A2 (en) | 1985-11-27 |
ES8801850A1 (en) | 1987-08-01 |
DK229985A (en) | 1985-11-25 |
EP0162812B1 (en) | 1993-09-01 |
ES8702950A1 (en) | 1987-01-16 |
DE3587553D1 (en) | 1993-10-07 |
JPH0770192A (en) | 1995-03-14 |
JPH07108915B2 (en) | 1995-11-22 |
IL75280A0 (en) | 1985-09-29 |
ES557071A0 (en) | 1988-02-16 |
IE60450B1 (en) | 1994-07-13 |
JPS60248617A (en) | 1985-12-09 |
ES543391A0 (en) | 1987-01-16 |
JPH0672158B2 (en) | 1994-09-14 |
ATE93869T1 (en) | 1993-09-15 |
ES8801852A1 (en) | 1988-02-16 |
DK171646B1 (en) | 1997-03-03 |
JPH0780915B2 (en) | 1995-08-30 |
EP0162812A3 (en) | 1988-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE851295L (en) | Monoclonal human mif | |
FI851334L (en) | NYA MONOCLONAL ANTIKROPPAR OCH HYBRIDOMACELLER, FOERFARANDE FOER FRAMSTAELLNING AV DESAMMA SAMT DERAS ANVAENDNING. | |
WO1989003846A3 (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
DK113389A (en) | MONOCLONAL ANTIBODIES | |
ATE245699T1 (en) | RECOMBINANT PGP3, METHOD FOR THE PRODUCTION THEREOF, AND ITS USE IN DIAGNOSIS AND THERAPY | |
EP0265384A3 (en) | Monoclonal antibodies to a colony stimulating factor | |
NO174110C (en) | Monoclonal antibody for use in vitro for the diagnosis of malignant tumor or acute inflammatory diseases and specific for N-acetyl neuraminic acid in hybridomas producing the antibody | |
ES2074420T3 (en) | MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN INDUCED BY PURE INTERFERENCE AND TEST KITS CONTAINING SUCH ANTIBODIES. | |
AU6189486A (en) | Monoclonal antibodies to prosomal proteins | |
Kishimoto et al. | Polymorphism of submandibular-sublingual salivary proteins which promote adhesion of Streptococcus mutans serotype-c strains to hydroxyapatite | |
HUT34547A (en) | Process for the purification of proteins isolated from microbe cultures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |